- Email: [email protected]
Raising standards
175
Volume 85, July 1996
product to cause transient flu symptoms in healthy individuals. The trial was placebo-controlled, randomized and double-blind. 77 out of 783 subjects who received homoeopathy compared to 17 of 790 on placebo experienced a proving reaction. Pearson two-tailed chi squared analysis gives ~2 at 41.3027, equivalent to the extremely small p value of 1.3 x 10,0. This trial quite accidentally provides perhaps the best evidence that homoeopathic preparations c o n t a i n i n g no m o l e c u l e s o f an a c t i v e substance can have biological effects in humans. A randomized trial in the prevention of influenzalike syndromes by homoeopathic treatment. Rev Epid6m et Sant6 Pub 1995; 43: 380--2.
Irregular regulation
in the management of HIV and a doubleblind, randomized, placebo-controlled trial has been started. Evaluation of homoeopathic therapy in the management of HIV disease. CCRH Quarterly Bulletin 1995; 11: 7-9.
Strange, rare and peculiar A. WARD Reviewing the materia medica of Sanicula aqua, the author describes the craving for a specific bottled water from Canada by a child who had not had her third birthday. Needless to say, the water came from the Ottawa spring which is the source of Sanicula, and the small patient who had worked out her own similim u m i m p r o v e d dramatically when given Sanicula 30c. The water contains a number of minerals that are widely used as polychrests, and the leading symptoms of the medicine prepared from it are presented in this paper. A forgotten polychrest~anicula aqua. The Homoeopath 1996; 61: 564-7.
R. G. PINCO, P. D. RUBIN The increased popularity of homoeopathic medicines in the USA has lead to a reversal of policies adopted by the Food and Drug Administration (FDA). As late as 1978 the FDA supported a bill that would have terminated the special legal status of homoeopathic medicines. The failure of this bill lead the FDA to issue a Compliance Policy Guide (CPC) in 1988. The e n f o r c e m e n t of this guide has been patchy, and the homoeopathic drug industry and the FDA continue to regard each other with suspicion. In Europe, the dual regulatory efforts of the European Union and of each member state have lead to an extremely complex situation. The authors believe that regulatory changes in the USA and Europe are likely to continue but are unwilling to guess whether matters will improve or deteriorate. Homeopathic drugs: what are they, and how are they regulated in the United States and in the European Union? Biological Therapy 1996; 14: 140-8.
SHEILA RYAN The author makes a plea for a more formal approach to supervised practice. This includes setting up a network of supervisors who are not only experienced homoeopaths but have received training in supervision. This will help the supervisors to allow the trainees to develop their own strengths and recognize their weaknesses, rather than simply copying the supervisor. Sheila Ryan makes a case for learning from, but not necessarily duplicating, other disciplines, such as counselling and psychotherapy, in which supervision has been more extensively used. She also recommends that such supervision needs to be costed as part of training. The case for supervision in homoeopathy. The Homoeopath 1996; 60: 521-7.
Homoeopathy and AIDS
Levels of similarity
D. P. RASTOGI, V. P. SINGH, VIKRAM SINGH, S. K. DEY, P. K. RAO Thirty patients were treated for 21 months with homoeopathic medicines selected on the basis of the totality of the patients' presenting signs and s y m p t o m s , their constitutional attributes, family history and past medical histories. The clinical and haematological results suggest that homoeopathy has a role
R. G. APPELL Rationality was growing dominant when Hahnemann formulated his principle of similarity in 1796, with other ways of thinking no longer acceptable. This has its effects to this day, even on homoeopaths. It is to some extent reductionist to limit similarity to disease picture and drug picture, when in fact it can be used creatively. Thus it is important to
Raising standards
Volume 85, July 1996
product to cause transient flu symptoms in healthy individuals. The trial was placebo-controlled, randomized and double-blind. 77 out of 783 subjects who received homoeopathy compared to 17 of 790 on placebo experienced a proving reaction. Pearson two-tailed chi squared analysis gives ~2 at 41.3027, equivalent to the extremely small p value of 1.3 x 10,0. This trial quite accidentally provides perhaps the best evidence that homoeopathic preparations c o n t a i n i n g no m o l e c u l e s o f an a c t i v e substance can have biological effects in humans. A randomized trial in the prevention of influenzalike syndromes by homoeopathic treatment. Rev Epid6m et Sant6 Pub 1995; 43: 380--2.
Irregular regulation
in the management of HIV and a doubleblind, randomized, placebo-controlled trial has been started. Evaluation of homoeopathic therapy in the management of HIV disease. CCRH Quarterly Bulletin 1995; 11: 7-9.
Strange, rare and peculiar A. WARD Reviewing the materia medica of Sanicula aqua, the author describes the craving for a specific bottled water from Canada by a child who had not had her third birthday. Needless to say, the water came from the Ottawa spring which is the source of Sanicula, and the small patient who had worked out her own similim u m i m p r o v e d dramatically when given Sanicula 30c. The water contains a number of minerals that are widely used as polychrests, and the leading symptoms of the medicine prepared from it are presented in this paper. A forgotten polychrest~anicula aqua. The Homoeopath 1996; 61: 564-7.
R. G. PINCO, P. D. RUBIN The increased popularity of homoeopathic medicines in the USA has lead to a reversal of policies adopted by the Food and Drug Administration (FDA). As late as 1978 the FDA supported a bill that would have terminated the special legal status of homoeopathic medicines. The failure of this bill lead the FDA to issue a Compliance Policy Guide (CPC) in 1988. The e n f o r c e m e n t of this guide has been patchy, and the homoeopathic drug industry and the FDA continue to regard each other with suspicion. In Europe, the dual regulatory efforts of the European Union and of each member state have lead to an extremely complex situation. The authors believe that regulatory changes in the USA and Europe are likely to continue but are unwilling to guess whether matters will improve or deteriorate. Homeopathic drugs: what are they, and how are they regulated in the United States and in the European Union? Biological Therapy 1996; 14: 140-8.
SHEILA RYAN The author makes a plea for a more formal approach to supervised practice. This includes setting up a network of supervisors who are not only experienced homoeopaths but have received training in supervision. This will help the supervisors to allow the trainees to develop their own strengths and recognize their weaknesses, rather than simply copying the supervisor. Sheila Ryan makes a case for learning from, but not necessarily duplicating, other disciplines, such as counselling and psychotherapy, in which supervision has been more extensively used. She also recommends that such supervision needs to be costed as part of training. The case for supervision in homoeopathy. The Homoeopath 1996; 60: 521-7.
Homoeopathy and AIDS
Levels of similarity
D. P. RASTOGI, V. P. SINGH, VIKRAM SINGH, S. K. DEY, P. K. RAO Thirty patients were treated for 21 months with homoeopathic medicines selected on the basis of the totality of the patients' presenting signs and s y m p t o m s , their constitutional attributes, family history and past medical histories. The clinical and haematological results suggest that homoeopathy has a role
R. G. APPELL Rationality was growing dominant when Hahnemann formulated his principle of similarity in 1796, with other ways of thinking no longer acceptable. This has its effects to this day, even on homoeopaths. It is to some extent reductionist to limit similarity to disease picture and drug picture, when in fact it can be used creatively. Thus it is important to
Raising standards